Logo image of NEPT

NEPTUNE WELLNESS SOLUTIONS I (NEPT) Stock Fundamental Analysis

NASDAQ:NEPT - Nasdaq - CA64079L3039 - Common Stock - Currency: USD

0.2  -0.17 (-45.95%)

After market: 0.19 -0.01 (-5%)

Fundamental Rating

1

Taking everything into account, NEPT scores 1 out of 10 in our fundamental rating. NEPT was compared to 35 industry peers in the Personal Care Products industry. NEPT has a bad profitability rating. Also its financial health evaluation is rather negative. NEPT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NEPT had negative earnings in the past year.
NEPT had a negative operating cash flow in the past year.
NEPT had negative earnings in each of the past 5 years.
In the past 5 years NEPT always reported negative operating cash flow.
NEPT Yearly Net Income VS EBIT VS OCF VS FCFNEPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of NEPT (-217.67%) is worse than 91.89% of its industry peers.
Industry RankSector Rank
ROA -217.67%
ROE N/A
ROIC N/A
ROA(3y)-110.99%
ROA(5y)-79.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NEPT Yearly ROA, ROE, ROICNEPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400

1.3 Margins

NEPT's Gross Margin of 8.55% is on the low side compared to the rest of the industry. NEPT is outperformed by 86.49% of its industry peers.
NEPT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NEPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.16%
NEPT Yearly Profit, Operating, Gross MarginsNEPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

NEPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NEPT has been increased compared to 1 year ago.
NEPT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NEPT has a worse debt to assets ratio.
NEPT Yearly Shares OutstandingNEPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50K 100K 150K 200K 250K
NEPT Yearly Total Debt VS Total AssetsNEPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

NEPT has an Altman-Z score of -31.64. This is a bad value and indicates that NEPT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NEPT (-31.64) is worse than 91.89% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -31.64
ROIC/WACCN/A
WACC2.34%
NEPT Yearly LT Debt VS Equity VS FCFNEPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

2.3 Liquidity

NEPT has a Current Ratio of 0.23. This is a bad value and indicates that NEPT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.23, NEPT is doing worse than 91.89% of the companies in the same industry.
NEPT has a Quick Ratio of 0.23. This is a bad value and indicates that NEPT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.10, NEPT is doing worse than 94.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.1
NEPT Yearly Current Assets VS Current LiabilitesNEPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.11% over the past year.
The Revenue for NEPT has decreased by -24.77% in the past year. This is quite bad
NEPT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.55% yearly.
EPS 1Y (TTM)72.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-274.77%
Revenue 1Y (TTM)-24.77%
Revenue growth 3Y33.25%
Revenue growth 5Y19.55%
Sales Q2Q%-37.76%

3.2 Future

The Earnings Per Share is expected to grow by 39.95% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -12.77% on average over the next years. This is quite bad
EPS Next Y80.15%
EPS Next 2Y39.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-37.18%
Revenue Next 2Y-12.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NEPT Yearly Revenue VS EstimatesNEPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
NEPT Yearly EPS VS EstimatesNEPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 -10K -20K -30K -40K -50K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NEPT. In the last year negative earnings were reported.
Also next year NEPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEPT Price Earnings VS Forward Price EarningsNEPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEPT Per share dataNEPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

A more expensive valuation may be justified as NEPT's earnings are expected to grow with 39.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.95%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NEPT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEPTUNE WELLNESS SOLUTIONS I

NASDAQ:NEPT (3/6/2024, 8:13:10 PM)

After market: 0.19 -0.01 (-5%)

0.2

-0.17 (-45.95%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-14 2023-11-14/amc
Earnings (Next)03-28 2024-03-28/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners13.83%
Ins Owner Change0%
Market Cap906.00K
Analysts43.33
Price Target20.85 (10325%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-106.35
EYN/A
EPS(NY)-9.22
Fwd EYN/A
FCF(TTM)-3.5
FCFYN/A
OCF(TTM)-3.41
OCFYN/A
SpS8.64
BVpS-6.9
TBVpS-7.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -217.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.55%
FCFM N/A
ROA(3y)-110.99%
ROA(5y)-79.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.16%
F-Score4
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.91%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.1
Altman-Z -31.64
F-Score4
WACC2.34%
ROIC/WACCN/A
Cap/Depr(3y)36.61%
Cap/Depr(5y)115.51%
Cap/Sales(3y)8.81%
Cap/Sales(5y)22.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-274.77%
EPS Next Y80.15%
EPS Next 2Y39.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.77%
Revenue growth 3Y33.25%
Revenue growth 5Y19.55%
Sales Q2Q%-37.76%
Revenue Next Year-37.18%
Revenue Next 2Y-12.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.58%
OCF growth 3YN/A
OCF growth 5YN/A